Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly? E Haehl, A Rühle, H David, T Kalckreuth, T Sprave, R Stoian, C Becker, ... Radiation Oncology 15, 1-12, 2020 | 67 | 2020 |
Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma? A Rühle, N Andratschke, S Siva, M Guckenberger Clinical and translational radiation oncology 18, 104-112, 2019 | 49 | 2019 |
Mesenchymal stem cells are sensitive to bleomycin treatment NH Nicolay, A Rühle, RL Perez, T Trinh, S Sisombath, KJ Weber, AD Ho, ... Scientific reports 6 (1), 26645, 2016 | 49 | 2016 |
Mesenchymal stem cells maintain their defining stem cell characteristics after treatment with cisplatin NH Nicolay, RL Perez, A Rühle, T Trinh, S Sisombath, KJ Weber, AD Ho, ... Scientific reports 6 (1), 20035, 2016 | 47 | 2016 |
The current understanding of mesenchymal stem cells as potential attenuators of chemotherapy‐induced toxicity A Rühle, PE Huber, R Saffrich, R Lopez Perez, NH Nicolay International journal of cancer 143 (11), 2628-2639, 2018 | 42 | 2018 |
De-escalation strategies of (chemo) radiation for head-and-neck squamous cell cancers—HPV and beyond A Rühle, AL Grosu, NH Nicolay Cancers 13 (9), 2204, 2021 | 40 | 2021 |
The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in … N Wiedenmann, AL Grosu, M Büchert, HC Rischke, J Ruf, L Bielak, ... Radiotherapy and Oncology 150, 128-135, 2020 | 32 | 2020 |
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients J Taugner, L Käsmann, C Eze, A Rühle, A Tufman, N Reinmuth, T Duell, ... Investigational new drugs 39, 1189-1196, 2021 | 31 | 2021 |
The radiation resistance of human multipotent mesenchymal stromal cells is independent of their tissue of origin A Rühle, O Xia, RL Perez, T Trinh, W Richter, A Sarnowska, P Wuchter, ... International Journal of Radiation Oncology* Biology* Physics 100 (5), 1259-1269, 2018 | 30 | 2018 |
The therapeutic potential of mesenchymal stromal cells in the treatment of chemotherapy-induced tissue damage A Rühle, R Lopez Perez, B Zou, AL Grosu, PE Huber, NH Nicolay Stem cell reviews and reports 15, 356-373, 2019 | 28 | 2019 |
The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer A Rühle, T Sprave, T Kalckreuth, R Stoian, E Haehl, C Zamboglou, ... Radiation Oncology 15, 1-13, 2020 | 26 | 2020 |
Mesenchymal stem cells exhibit resistance to topoisomerase inhibition NH Nicolay, A Rühle, RL Perez, T Trinh, S Sisombath, KJ Weber, ... Cancer letters 374 (1), 75-84, 2016 | 26 | 2016 |
18F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy M Carles, T Fechter, AL Grosu, A Sörensen, B Thomann, RG Stoian, ... Cancers 13 (14), 3449, 2021 | 25 | 2021 |
Mesenchymal stem cells preserve their stem cell traits after exposure to antimetabolite chemotherapy RL Perez, F Münz, D Vidoni, A Rühle, T Trinh, S Sisombath, B Zou, ... Stem cell research 40, 101536, 2019 | 24 | 2019 |
Radiotherapy-induced heart disease: a review of the literature B Zou, JP Schuster, K Niu, Q Huang, A Rühle, PE Huber Precision Clinical Medicine 2 (4), 270-282, 2019 | 23 | 2019 |
Development and validation of a novel prognostic score for elderly head-and-neck cancer patients undergoing radiotherapy or chemoradiation A Rühle, C Stromberger, E Haehl, C Senger, H David, R Stoian, ... Radiotherapy and Oncology 154, 276-282, 2021 | 22 | 2021 |
Lymphocyte infiltration determines the hypoxia-dependent response to definitive chemoradiation in head-and-neck cancer: results from a prospective imaging trial NH Nicolay, A Rühle, N Wiedenmann, G Niedermann, M Mix, WA Weber, ... Journal of Nuclear Medicine 62 (4), 471-478, 2021 | 18 | 2021 |
The value of laboratory parameters for anemia, renal function, systemic inflammation and nutritional status as predictors for outcome in elderly patients with head-and-neck cancers A Rühle, E Haehl, H David, T Kalckreuth, T Sprave, R Stoian, ... Cancers 12 (6), 1698, 2020 | 17 | 2020 |
Financial toxicity in cancer patients treated with radiotherapy in Germany—a cross-sectional study A Fabian, J Domschikowski, W Greiner, G Bockelmann, E Karsten, ... Strahlentherapie und Onkologie 198 (12), 1053-1061, 2022 | 16 | 2022 |
Hypoxia dynamics on FMISO-PET in combination with PD-1/PD-L1 expression has an impact on the clinical outcome of patients with Head-and-neck Squamous Cell Carcinoma undergoing … A Rühle, AL Grosu, N Wiedenmann, M Mix, R Stoian, G Niedermann, ... Theranostics 10 (20), 9395, 2020 | 16 | 2020 |